» Articles » PMID: 26105823

Antibody Informatics: IMGT, the International ImMunoGeneTics Information System

Overview
Specialty Microbiology
Date 2015 Jun 25
PMID 26105823
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Antibody informatics, a part of immunoinformatics, refers to the concepts, databases, and tools developed and used to explore and to analyze the particular properties of the immunoglobulins (IG) or antibodies, compared with conventional genes and proteins. Antibody informatics is based on a unique ontology, IMGT-ONTOLOGY, created in 1989 by IMGT, the international ImMunoGeneTics information system (http://www.imgt.org). IMGT-ONTOLOGY defined, for the first time, the concept of 'genes' for the IG and the T cell receptors (TR), which led to their gene and allele nomenclature and allowed their entry in databases and tools. A second IMGT-ONTOLOGY revolutionizing and definitive concept was the IMGT unique numbering that bridged the gap between sequences and structures for the variable (V) and constant (C) domains of the IG and TR, and for the groove (G) domains of the major histocompatibility (MH). These breakthroughs contributed to the development of IMGT databases and tools for antibody informatics and its diverse applications, such as repertoire analysis in infectious diseases, antibody engineering and humanization, and study of antibody/antigen interactions. Nucleotide sequences of antibody V domains from deep sequencing (Next Generation Sequencing or High Throughput Sequencing) are analyzed with IMGT/HighV-QUEST, the high-throughput version of IMGT/V-QUEST and IMGT/JunctionAnalysis. Amino acid sequences of V and C domains are represented with the IMGT/Collier-de-Perles tool and analyzed with IMGT/DomainGapAlign. Three-dimensional (3D) structures (including contact analysis and paratope/epitope) are described in IMGT/3Dstructure-DB. Based on a friendly interface, IMGT/mAb-DB contains therapeutic monoclonal antibodies (INN suffix-mab) that can be queried on their specificity, for example, in infectious diseases, on bacterial or viral targets.

Citing Articles

50 Years of Antibody Numbering Schemes: A Statistical and Structural Evaluation Reveals Key Differences and Limitations.

Zhu Z, Olson K, Magliery T Antibodies (Basel). 2024; 13(4).

PMID: 39727482 PMC: 11672675. DOI: 10.3390/antib13040099.


A novel shark VNAR antibody-based immunotoxin targeting TROP-2 for cancer therapy.

Xi X, Wang Y, An G, Feng S, Zhu Q, Wu Z Acta Pharm Sin B. 2024; 14(11):4806-4818.

PMID: 39664437 PMC: 11628804. DOI: 10.1016/j.apsb.2024.08.023.


Using IMGT unique numbering for IG allotypes and Fc-engineered variants of effector properties and half-life of therapeutic antibodies.

Lefranc M, Lefranc G Immunol Rev. 2024; 328(1):473-506.

PMID: 39367563 PMC: 11659927. DOI: 10.1111/imr.13399.


The Longitudinal Analysis of Convergent Antibody VDJ Regions in SARS-CoV-2-Positive Patients Using RNA-Seq.

Liu K, Zelazowska M, McBride K Viruses. 2023; 15(6).

PMID: 37376553 PMC: 10304081. DOI: 10.3390/v15061253.


B cell M-CLL clones retain selection against replacement mutations in their immunoglobulin gene framework regions.

Neuman H, Arrouasse J, Benjamini O, Mehr R, Kedmi M Front Oncol. 2023; 13:1115361.

PMID: 37007112 PMC: 10060519. DOI: 10.3389/fonc.2023.1115361.